The epidermal growth factor receptor and its ligand family: Their potential role in repair and remodelling in asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 8, 1999, Pages 771-783

  Davies, Donna E ^a   Polosa, R ^a   Puddicombe, S M ^a   Richter, A ^a   Holgate, S T ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Asthma; C erbB1; Epidermal growth factor (EGF); Epidermal growth factor receptor; Epithelial repair

Indexed keywords

AUTACOID; CELL ADHESION MOLECULE; EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND; MATRIX PROTEIN; METALLOPROTEINASE; MUCIN; PROTEIN TYROSINE KINASE;

ASTHMA; BIOCHEMISTRY; BRONCHUS MUCOSA; CELL FUNCTION; CHRONIC DISEASE; HUMAN; LUNG INJURY; MEDIATOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; ASTHMA; BRONCHI; EPITHELIUM; HUMANS; MUCOUS MEMBRANE; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 0032779202     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (132)

1. 1. Dunnill MS. The pathology of asthma with special reference to changes in the bronchial mucosa. J Clin Pathol 1960;13:27-33.
2. 2. Dunnill MS, Massarella GR, Anderson JA. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax 1969;24:176-179.
3. 3. Laitinen LA, Heino M, Laitinen A, Kava T, Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985;131:599-606.
4. 4. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989;139:806-817.
5. 5. Jeffery PK, Wardlaw JA, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140:1745-1753.
6. 6. Montefort S, Roberts JA, Beasley R, Holgate ST, Ruche WR. The site of disruption of the bronchial epithelium in asthmatic and nonasthmatic subjects. Thorax 1992;47:499-503.
7. 7. Djukanovic R, Roche WR, Wilson JW, Beasley CRW, Twentyman OP, Howarth PH. Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142:434-457.
8. 8. Frigas E, Loegering DA, Gleich GJ. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab Invest 1980;42:35-43.
9. 9. Walls AF, Shute JK, Warner J, Cairns JA, Howarth PH, Holgate ST. Mast cell and eosinophil proteases in the chronic allergic inflammatory response. In: Marone G, Austen KF, Lichtenstein L, Kay AB, Holgate ST, editors. Asthma, physiology, immunopharmacology and treatment. Academic Press, 1998:119-131.
10. 10. Redington AE, Polosa R, Walls AF, Howarth PH, Holgate ST. Role of mast-cells and basophils in asthma. Chem Immunol 1995;61:22-59.
11. 11. Herbert CA, Edwards DJ, Boot JR, Robinson C. Stimulated eosinophils and proteinases augment the transepithelial flux of albumin in bovine bronchial mucosa. Br J Pharmacol 1993;10:840-846.
12. 12. Herbert CA, King CM, Ring PC, et al. Augmentation of permeability in the bronchial epithelium by the house dust mite allergen Der p 1. Am J Respir Cell Mol Biol 1995;12:369-378.
13. 13. Hassim Z, Maronese SE, Kumar RK. Injury to airway epithelial cells by pollen enzymes. Thorax 1998;53:368-371.
14. 14. Winton HL, Wan H, Cannell MB, et al. Class specific inhibition of house dust mite proteinases which cleave cell adhesion, induce cell death and increase the permeability of lung epithelium. Br J Pharmacol 1998;124:1048-1059.
15. 15. Chen LL, Ferrando RE, Christian DL, Welch BS, Sheppard D, Balmes JR. Comparison of integrin expression in asthmatic versus normal bronchial epithelium. Am J Respir Crit Care Med 1996;153:A646.
16. 16. Peroni DG, Djukanović R, Bradding P, et al. Expression of CD44 and integrins in bronchial mucosa of normal and mildly asthmatic subjects. Eur Respir J 1996;9:2236-2242.
17. 17. Bullock GR, Campbell AM, Warhol MJ, Multhaupt HAB, Bousquet J. Expression of E-cadherin and alpha, beta and gamma-catenin is associated with epithelial shedding in human lung and nose. J Allergy Clin Immunol 1998;101:459.
18. 18. Vignola AM, Campbell AM, Chanez P, et al. HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. Am Rev Respir Dis 1993;148:689-694.
19. 19. Lackie PM, Baker JE, Günthert U, Holgate ST. Expression of CD44 isoforms is increased in the airway epithelium of asthmatic subjects. Am J Respir Cell Mol Biol 1997;16:14-22.
20. 20. Devalia JL, Davies RJ. Airway epithelial cells and mediators of inflammation. Respir Med 1993;87:405-408.
21. 21. Marini M, Vittori E, Hollemborg J, Mattoli S. Expression of the potent inflammatory cytokines, granulocyte-macrophage colony stimulating factor and interleukin-6 and interleukin-8 in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol 1992;89:1001-1009.
22. 22. Campbell AM. Bronchial epithelial cells in asthma. Allergy 1997;52:483-489.
23. 23. Holgate ST. Asthma: a dynamic disease of inflammation and repair. In: The rising trends of asthma. (Ciba Foundation Symposium 206). Chichester: Wiley, 1996:5-34.
24. 24. King C, Brennan S, Thompson PJ, Stewart GA. Dust mite allergens induce cytokine release from cultured airway epithelium. J Immunol 1998;161:3645-3651.
25. 25. Cairns JA, Walls AF. Mast cell tryptase is a mitogen for epithelial cells: stimulation of IL-8 production and ICAM-1 expression. J Immunol 1996;156:275-283.
26. 26. Yamaya M, Sekizawa K, Masuda T, Morikawa M, Sawai T, Sasaki H. Oxidants affect permeability and repair of the cultured human trachea. Am J Physiol 1995;268:L284-293.
27. 27. Johnston SL. Natural and experimental rhinovirus infections of the lower respiratory tract. Am J Respir Crit Care Med 1994;152:S46-S52.
28. 28. Van-Alphen L. Interaction of bacteria and the airway epithelial cells. Eur Respir J 1996;9:1342-1343.
29. 29. Johnston CJ, Stripp BR, Piedbeouf B, et al. Inflammatory and epithelial responses in mouse strains that differ in sensitivity to hyperoxic injury. Exp Lung Res 1998;24:189-202.
30. 30. Hou L, Kapas S, Cruchley AT, et al. Immunolocalization of protease-activated receptor-2 in skin: receptor activation stimulates interleukin-8 secretion by keratinocytes in vitro. Immunology 1998;94:356-362.
31. 31. Rahman I, MacNee W. Role of transcription factors in inflammatory lung diseases. Thorax 1998;53:601-612.
32. 32. Erjefält JS, Sundler F, Persson CGA. Structural changes in the airways after acute and repeated denudation in vivo. Am Rev Respir Crit Care Med 1995;151:698.
33. 33. Brewster CE, Howarth PH, Djukanović R, Wilson J, Holgate ST, Roche WR. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990;3:507-511.
34. 34. Hoshino M, Nakamura Y, Sim JJ. Expression of growth factors and remodelling of the airway wall in bronchial asthma. Thorax 1998;53:21-27.
35. 35. Zhang S, Smartt H, Holgate ST, Roche WR. Growth factors secreted by bronchial epithelial cells control myofibroblast proliferation: an in vitro co-culture model of airway remodelling in asthma. Lab Invest 1999;79:395-405.
36. 36. Erjefält JS, Erjefält I, Sundler F, Persson CG. In vivo restitution of airway epithelium. Cell Tissue Res 1995;281:305-316.
37. 37. Carpenter G, Wahl MI. The epidermal growth factor family. In: Sporn MB, Roberts AB, editors. Peptide growth factors and their receptors. New York: Springer-Verlag, 1991:69-171.
38. 38. Lawrence WT, Diegelmann RF. Growth factors in wound healing. Clin Dermatol 1994;12:157-169.
39. 39. McCarthy DW, Downing MT, Brigstock DR, et al. Production of heparin-binding epidermal growth factor-like growth factor (HB-EGF) at sites of thermal injury in paediatric patients. J Invest Dermatol 1996;106:49-56.
40. 40. Brown GL, Curtsinger L, Brightwell JR, et al. Enhancement of epidermal regeneration by biosynthetic epidermal growth factor. J Exp Med 1986;163:1319-1324.
41. 41. Cohen S. Isolation of mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J Biol Chem 1962;237:1555-1562.
42. 42. Gregory H. Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature 1975;257:325-327.
43. 43. DeLarco JE, Reynolds R, Carlberg K, Engle C, Todaro GJ. Sarcoma growth factor from mouse sarcoma virus-transformed cells. Purification by binding and clution from epidermal growth factor receptor rich cells. J Biol Chem 1980;255:3685-3690.
44. 44. Shoyab M, McDonald VL, Bradley JG, Todaro GJ. Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7. Proc Natl Acad Sci U S A 1988;85:6528-6532.
45. 45. Higashiyama S, Lau K, Besner G, Abraham JA, Klagsbrun M. A heparin-binding EGF-like growth factor secreted by macrophage-like cells is related to EGF. Science 1991;251:936-939.
46. 46. Shing Y, Christofori G, Hanahan n, et al. Betacellulin: a mitogen from pancreatic β-cell tumors. Science 1993;259:1604-1607.
47. 47. Toyoda H, Komurasaki T, Uchida D, et al. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J Biol Chem 1995;270:7495-7500.
48. 48. Campbell ID, Cooke RM, Baron M, Harvey TS, Tappin MJ. The solution structures of epidermal growth factor and transforming growth factor alpha. Prog Growth Factor Res 1989;1:13-12.
49. 49. Taylor JM, Mitchell WM, Cohen S. Epidermal growth factor. Physical and chemical properties. J Biol Chem 1972;247:5928-5934.
50. 50. Higashiyama S, Lau K, Besner GE, Abraham JA, Klagsbrun M. Structure of heparin-binding EGF-like growth factor. J Biol Chem 1992;267:6205-6212.
51. 51. Goishi K, Higashiyama S, Klagsbrun M, et al. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol Biol Cell 1995;6:967-980.
52. 52. Arribas J, Coodly L, Vollmer P, Kishimoto TK, Rose-John S, Massague J. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J Biol Chem 1996;271:11376-11382.
53. 53. Suzuki M, Raab G, Moses MA, Fernandez CA, Klagsbrun M. Matrix metalloproteinase-3 releases active heparin-binding EGF like growth factor by cleavage of a specific juxtamembrane site. J Biol Chem 1997;272:31730-31737.
54. 54. Dethlefsen SM, Raab G, Moses MA, Adam RM, Klagsbrun M, Freeman MR. Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C. J Cell Biochem 1998;69:143-153.
55. 55. Dahlén B, Shute JK, Howart PH. Matrix metalloproteinases in asthma: evidence of upregulated activation pathways in relation to disease and assessment of airway tissue localisation. Thorax 1999 (in press).
56. 56. Lees M, Taylor DJ, Woolley DE. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinase A and B. Eur J Biochem 1994;223:171-177.
57. 57. Schreiber AB, Winkler ME, Derynck R. Transforming growth factor-α: a more potent angiogenic mediator than epidermal growth factor. Science 1986;32:1250-1253.
58. 58. Stern PH, Krieger NS, Nissenson RA, et al. Human transforming growth factor alpha stimulates bone resorption in vitro. J Clin Invest 1985;76:2016-2019.
59. 59. Johnson GR, Wong L. Heparan sulphate is essential to amphiregulin-induced mitogenic signaling by the epidermal growth factor receptor. J Biol Chem 1994;269:27149-27154.
60. 60. Besner GE, Whelton D, Crissman-Combs MA, Steffen CL, Kim GY, Brigstock DR. Modulation of heparin-binding EGF-like growth factor (HB-EGF) with the epidermal growth factor receptor: modulation by heparin, heparinase, or synthetic heparin-binding HB EGF fragments. Growth Factors 1992;7:289-296.
61. 61. Bennett KL, Jackson DJ, Simon JC, et al. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding EGF. J Cell Biol 1995;128:687-698.
62. 62. Prigent SA, Lemoine NR. The type 1 (EGFR-related) family of growth factor receptors and their ligands. Prog Growth Factor Res 1992;4:1-14.
63. 63. Earp HS, Dawson TL, Li X, Yu H. Heterodimerization and functional interactions between EGF receptor family members - a new signaling paradigm with implications for breast cancer research. Breast Cancer Res Treat 1995;35:115-132.
64. 64. Tzahar E, Levkowitz G, Karunagaran D, et at. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors for all neu differentiation factor/heregulin isoforms. J Biol Chem 1994;269:25226-25233.
65. 65. Carraway KL, Weber JL, Unger MJ, et al. Neuregulin-2, a new ligand of ErbB3/ ErbB4-receptor tyrosine kinases. Nature 1997;387:512-516.
66. 66. Hijazi MM, Young PE, Dougherty MK, et al. NRG-3 in human breast cancers: activation of multiple erbB family proteins. Int J Oncol 1998;13:1061-1067.
67. 67. Lemmon MA, Schlessinger J. Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem Sci 1994;19:459-463.
68. 68. Carraway KL, Cantley LC. A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell 1994;78:5-8.
69. 69. Tzahar E, Waterman H, Chen X, et al. A hierarchical network of interreceptor interactions determines signal transduction by neu differentiation factor/neuregulin and epidermal growth factor. Mol Cell Biol 1996;16:5276-5287.
70. 70. Graus-Porta D, Beerli R, Daly JM, Hynes NE. ErbB-2, the preferred heterodimerisation partner of all ErbB receptors, is a mediator of lateral signalling. EMBO J 1997;16:1647-1655.
71. 71. Karunagaran D, Tzahar E, Beerli RR, et al. ErbB2 is a common signalling subunit of NDF and EGF receptors: implications for breast cancer. EMBO J 1996;15:254-264.
72. 71. Schroeder JA, Lee DC. Dynamic expression and activation of erbB receptors in the developing mouse mammary gland. Cell Growth Differ 1998;9:451-464.
73. 73. Sundaresan S, Roberts PE, King KL, Sliwkowski MX, Mather JP. Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression. Endocrinology 1998;139:4756-4764.
74. 74. Riese DJ, van Raaij TM, Plowman GD, Andrews GC, Stern DS. The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol Cell Biol 1995;15:5770-5776.
75. 75. Pinkas-Kramarski R, Soussan L, Waterman H, et al. Diversification of neu differentiation factor and epidermal growth factor signalling by combinatorial receptor interactions. EMBO J 1996;15:2452-2467.
76. 76. Riese DJ, Bermingham Y, Raaij TM, Buckley S, Plowman GD, Stern DF. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. Oncogene 1996;12:345-354.
77. 77. Lee J, Dull TJ, Lax I, Schlessinger J, Ullrich A. HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor. EMBO J 1989;8:167-173.
78. 78. Guy PM, Platko JV, Cantley LC, Cerione RA, Carraway KL. Insect cell-expressed p180(erbB3) possesses an impaired tyrosine kinase activity. Proc Natl Acad Sci U S A 1994;91:8132-8136.
79. 79. Fedi P, Pierce JH, Di Fiore PP, Kraus MH. Efficient coupling with PI-3-K, but not PLC-γ or GAP, distinguishes erbB3 signalling from that of other ErbB/EGFR family members. Mol Cell Biol 1994;14:492-500.
80. 80. Baulida J, Kraus MH, Alimandi M, DiFiore PP, Carpenter G. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J Biol Chem 1996;271:5251-5257.
81. 81. Waterman H, Sabanai I, Geiger B, Yarden Y. Alternative intracellular routing of ErbB receptors may determine signaling potency. J Biol Chem 1998;273:13819-13827.
82. 82. Elenius K, Paul S, Allison G, Sun J, Klagsbrun M. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J 1997;16:1268-1278.
83. 83. Shelly M, Pinkas Kramarski R, Guarino BC, et al. Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes. J Biol Chem 1998;273:10496-10505.
84. 84. Alimandi M, Wang LM, Bottaro D, et al. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. EMBO J 1997;16:5608-5617.
85. 85. Aida S, Tamai S, Sekiguchi S, Shimizu N. Distribution of epidermal growth factor and epidermal growth factor receptor in human lung: immunohistochemical and immunoelectron-microscopic studies. Respiration 1994;61:161-166.
86. 86. Polosa R, Prosperini G, Leir S-H, Holgate ST, Lackie PM, Davies DE. Expression of c-erbB receptors and ligands in human bronchial mucosa. Am J Respir Cell Mol Biol 1999;20:914-923.
87. 87. Kumar RK, O'Grady R, Di Girolamo N. Epidermal growth factor-like molecular species in normal bronchoalveolar lavage fluid. Lung 1996;174:171-179.
88. 88. Klein SB, Fisher GJ, Jensen TC, Mendelsohn J, Voorhees JJ, Elder JT. Regulation of TGF-alpha expression in human keratinocytes: PKC-dependent and -independent pathways. J Cell Physiol 1992;151:326-336.
89. 89. Barnard JA, Graves-Deal R, Pittelkow MR, et al. Auto-and cross-induction within the mammalian epidermal growth factor-related peptide family. J Biol Chem 1994;269:22817-22822.
90. 90. DiMarco E, Pierce JH, Fleming TP, et al. Autocrine interaction between TGF-alpha and the EGF receptor: quantitative requirements for induction of the malignant phenotype. Oncogene 1989;4:831-838.
91. 91. Strandjord TP, Clark JG, Guralnick DE, Madres DK. Immunolocalization of transforming growth factor alpha, epidermal growth factor (EGF) and EGF-receptor in normal and injured developing human lung. Pediatr Res 1995;38:851-856.
92. 92. Tsao MS, Zhu H, Viallet J. Autocrine growth loop of the epidermal growth factor receptor in normal and immortalized human bronchial epithelial cells. Exp Cell Res 1996;223:268-273.
93. 93. Asano K, Nakamura H, Lilly CM, Klagsbrun M, Drazen JM. Interferon gamma induces prostaglandin G/H synthase-2 through an autocrine loop via the epidermal growth factor receptor in human bronchial epithelial cells. J Clin Invest 1997;99:1057-1063.
94. 94. Madtes D, Raines EW, Sakariassen KS, et al. Induction of transforming growth factor alpha in activated human alveolar macrophages. Cell 1988;53:285-293.
95. 95. Wong DTW, Weller PF, Galli SJ, et al. Human eosinophils express transforming growth factor alpha. J Exp Med 1990;172:673-681.
96. 96. Marikovsky M, Breuing K, Liu PY, et al. Appearance of HB-EGF in wound fluid as a response to injury. Proc Natl Acad Sci U S A 1993;90:3889-3893.
97. 97. Powell PP, Klagsbrun M, Abraham JA, Jones RC. Eosinophils expressing HB-EGF mRNA localize around lung microvessels in pulmonary hypertension. Am J Pathol 1993;143:784-793.
98. 98. Ghiabi M, Gallagher GT, Wong DTW. Eosinophils, tissue eosinophilia, and eosinophil-derived transforming growth factor-alpha in hamster oral carcinogenesis. Cancer Res 1992;52:389-393.
99. 99. Blotnick S, Peoples GE, Freeman MR, Eberlein TJ, Klagsbrun M. T-lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth-factor and basic fibroblast growth-factor, mitogens for vascular cells and fibroblasts -differential production and release by CD4+ and CD8+ T-cells. Proc Natl Acad Sci U S A 1994;91:2890-2894.
100. 100. Hwang DL, Lev-Ran A, Yen CF, Sniecinski T. Release of different fractions of epidermal growth factor from human platelets in vitro: preferential release of 140 kDa fraction. Regul Pept 1992;37:95-100.
101. 101. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeleton. J Cell Biol 1994;126:391-401.
102. 102. Stahlman MT, Orth DN, Gray ME. Immunocytochemical localization of epidermal growth factor in the developing human respiratory system and in acute and chronic lung disease in the neonate. Lab Invest 1989;60:539-547.
103. 103. Lesur O, Arsalane K, Lane D. Lung alveolar epithelial cell migration in vitro: modulators and regulation processes. Am J Physiol Lung Cell Mol Physiol 1996;270:L311-319.
104. 104. Leslie CC, McCormick Shannon K, Shannon JM, et al. Heparin-binding EGF-like growth factor is a mitogen for rat alveolar type II cells. Am J Respir Cell Mol Biol 1997;16:379-387.
105. 105. Barrow RE, Wang CZ, Evans MJ, Herndon DN. Growth factors accelerate epithelial repair in sheep trachea. Lung 1993;171:335-344.
106. 106. Tesfaigzi J, Johnson NF, Lechner JF. Induction of EGF receptor and c-erbB2 during endotoxin-induced alveolar type II cell proliferation in the rat lung. Int J Exp Pathol 1996;77:143-154.
107. 107. Madtes DK, Busby HK, Strandjord TP, Clark JG. Expression of transforming growth factor-α and epidermal growth factor receptor is increased following bleomycin-induced lung injury in rats. Am J Respir Cell Mol Biol 1994;11:540-551.
108. 108. Van Winkle LS, Isaac JM, Plopper CG. Distribution of epidermal growth factor receptor and ligands during bronchiolar epithelial repair from naphthalene-induced Clara cell injury in the mouse. Am J Pathol 1997;151:443-459.
109. 109. Polosa R, Dokic D, Prosperini G, Holgate ST, Davies DE, Howarth PH. Ozone exposure elicits overexpression of the epidermal growth factor receptor and its ligands in human nasal epithelium. Eur Respir J 1998;12 Suppl 28:3175.
110. 110. Chamberlin SG, Davies DE. A unified model of c-erbB receptor homo-and heterodimerization. Biochim Biophys Acta 1998;1384:223-232.
111. 111. Chesnutt AN, Kheradmand F, Folkesson HG, Alberts M, Matthay MA. Soluble transforming growth factor-alpha is present in the pulmonary edema fluid of patients with acute lung injury. Chest 1997:111:652-656.
112. 112. Folkesson HG, Pittet JF, Nitenberg G, Matthay MA. Transforming growth factor-alpha increases alveolar liquid clearance in anesthetized ventilated rats. Am J Physiol Lung Cell Mol Physiol 1996;271:L236-244.
113. 113. Vivekananda J, Lin A, Coalson JJ, King RJ. Acute inflammatory injury in the lung precipitated by oxidant stress induces fibroblasts to synthesize and release transforming growth factor-alpha. J Biol Chem 1994;269:25057-25061.
114. 114. Kheradmand F, Folkesson HG, Shum L, Derynck R, Pytela R, Mattay MA. Transforming growth factor-alpha enhances alveolar epithelial cell repair in a new in vitro model. Am J Physiol Lung Cell Mol Physiol 1994;267:L728-738.
115. 115. Kim JS, McKinnis VS, Nawrocki A, White SR. Stimulation of migration and wound repair of guinea-pig airway epithelial cells in response to epidermal growth factor. Am J Respir Cell Mol Biol 1998;18:66-74.
116. 116. Korfhagen TR, Swantz RJ, Wert SE, et al. Respiratory epithelial cell expression of human transforming growth factor α induces lung fibrosis in transgenic mice. J Clin Invest 1994;93:1691-1699.
117. 117. Hardie WD, Kerlakian CB, Bruno MD, et al. Reversal of lung lesions in transforming growth factor α mice by expression of mutant epidermal growth factor receptor. Am J Respir Cell Mol Biol 1996;15:499-508.
118. 118. Miettinen PJ, Warburton D, Bu D, et al. Impaired lung branching morphogenesis in the absence of functional EGF receptor. Dev Biol 1997;186:224-246.
119. 119. Amishima M, Munakata M, Nasuhara Y, et al. Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway. Am J Respir Crit Care Med 1998;157:1907-1912.
120. 120. Polosa R, Krishna MT, Howarth P, Lackie PM, Holgate ST, Davies DE. Elevated epidermal growth factor receptor (EGFR) expression in bronchial epithelium of mild and severe asthmatics. Eur Respir J 1998;12 Suppl 29:56s.
121. 121. Puddicombe SM, Holgate ST, Davies DE. The role of the epidermal growth factor receptor (EGFR) in bronchial epithelial repair. Eur Respir J 1998;12 suppl 29:29s.
122. 122. Richter A, Holgate ST, Davies DE. Involvement of the epidermal growth factor receptor (EGFR) in the response of bronchial epithelial cells to oxidant stress. Eur Respir J 1998;12 Suppl 29:29s.
123. 123. Schmiegel W, Roeder C, Schmielau J, Rodeck U, Kalthoff H. Tumor necrosis factor α induces the expression of transforming growth factor α and the epidermal growth factor receptor in human panceatic cancer cells. Proc Natl Acad Sci U S A 1993;90:863-867.
124. 123]-epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol 1986;86:260-265.
125. 125. Rusch V, Baselga J, Cordon-Cardo C, et al. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res 1993;53:2379-2385.
126. 126. Dermoly P, Simony-Lafontaine J, Chanez P, et al. Cell proliferation in the bronchial mucosa of asthmatics and chronic bronchitics. Am J Respir Crit Care Med 1994;150:214-217.
127. 127. Moghal N, Neel B. Integration of growth factor, extracellular matrix, and retinoid signals during bronchial epithelial cell differentiation. Mol Cell Biol 1998;18:6666-6678.
128. 128. Rennard S. Repair of the airway epithelium: potential opportunities for therapeutic intervention in airway disease. Allergol Int 1998;47:91-97.
129. 129. Kretzschmar M, Doody J, Massague J. Opposing effects of BMP and EGF signalling pathways converge on the TGF-β family mediator Smadi. Nature 1997;389:617-622.
130. 130. Vignola AM, Chanez P, Chiappara G, et al. Transforming growth factor-β expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 1997;156:591-595.
131. 131. Fujitani Y, Bertrand C. ET-1 co-operates with EGF to induce mitogenesis via a PTX-sensitive pathway in airway smooth muscle cells. Am J Physiol 1997;41:C1492-1498.
132. 4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am J Respir Cell Mol Biol 1998;19:453-461.